Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Banerjea

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
International Journal of Colorectal Disease|May 3, 2020
Thrombocytosis helps to stratify risk of colorectal cancer in patients referred on a 2-week-wait pathwayJ A Bailey, N Hanbali, K Premji, et al.
BJS Open|June 12, 2019
Service evaluation of faecal immunochemical testing and anaemia for risk stratification in the 2-week-wait pathway for colorectal cancerC Chapman, J Bunce, S Oliver, et al.
Langenbeck'S Archives of Surgery|June 15, 2021
Planned surgery in the COVID-19 pandemic: a prospective cohort study from NottinghamJ Catton, A Banerjea, S Gregory, et al.
Techniques in Coloproctology|July 15, 2021
Quantitative FIT stratification is superior to NICE referral criteria NG12 in a high-risk colorectal cancer populationJ A Bailey, H Ibrahim, J Bunce, et al.
Annals of the Royal College of Surgeons of England|March 16, 2018
Anaemia as a risk stratification tool for symptomatic patients referred via the two-week wait pathway for colorectal cancerS Mashlab, P Large, W Laing, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|January 4, 2024
'Low' faecal immunochemical test (FIT) colorectal cancer: a 4-year comparison of the Nottingham '4F' protocol with FIT10 in symptomatic patientsJ A Bailey, A J Morton, J Jones, et al.
BJS Open|March 11, 2021
Faecal immunochemical testing and blood tests for prioritization of urgent colorectal cancer referrals in symptomatic patients: a 2-year evaluationJ A Bailey, J Weller, C J Chapman, et al.
The Surgeon : Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland|April 25, 2020
GP access to FIT increases the proportion of colorectal cancers detected on urgent pathways in symptomatic patients in NottinghamJ A Bailey, A Khawaja, H Andrews, et al.
Techniques in Coloproctology|May 3, 2023
CT-derived measures of muscle quantity and quality predict poorer outcomes from elective colorectal surgery: a UK multicentre retrospective cohort studyJ E M Blackwell, P J J Herrod, B Doleman, et al.
Alimentary Pharmacology & Therapeutics|January 7, 2025
COLOFIT: Development and Internal-External Validation of Models Using Age, Sex, Faecal Immunochemical and Blood Tests to Optimise Diagnosis of Colorectal Cancer in Symptomatic PatientsC J Crooks, J West, J Jones, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
International Journal of Colorectal Disease|May 3, 2020
Thrombocytosis helps to stratify risk of colorectal cancer in patients referred on a 2-week-wait pathwayJ A Bailey, N Hanbali, K Premji, et al.
BJS Open|June 12, 2019
Service evaluation of faecal immunochemical testing and anaemia for risk stratification in the 2-week-wait pathway for colorectal cancerC Chapman, J Bunce, S Oliver, et al.
Langenbeck'S Archives of Surgery|June 15, 2021
Planned surgery in the COVID-19 pandemic: a prospective cohort study from NottinghamJ Catton, A Banerjea, S Gregory, et al.
Techniques in Coloproctology|July 15, 2021
Quantitative FIT stratification is superior to NICE referral criteria NG12 in a high-risk colorectal cancer populationJ A Bailey, H Ibrahim, J Bunce, et al.
Annals of the Royal College of Surgeons of England|March 16, 2018
Anaemia as a risk stratification tool for symptomatic patients referred via the two-week wait pathway for colorectal cancerS Mashlab, P Large, W Laing, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|January 4, 2024
'Low' faecal immunochemical test (FIT) colorectal cancer: a 4-year comparison of the Nottingham '4F' protocol with FIT10 in symptomatic patientsJ A Bailey, A J Morton, J Jones, et al.
BJS Open|March 11, 2021
Faecal immunochemical testing and blood tests for prioritization of urgent colorectal cancer referrals in symptomatic patients: a 2-year evaluationJ A Bailey, J Weller, C J Chapman, et al.
The Surgeon : Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland|April 25, 2020
GP access to FIT increases the proportion of colorectal cancers detected on urgent pathways in symptomatic patients in NottinghamJ A Bailey, A Khawaja, H Andrews, et al.
Techniques in Coloproctology|May 3, 2023
CT-derived measures of muscle quantity and quality predict poorer outcomes from elective colorectal surgery: a UK multicentre retrospective cohort studyJ E M Blackwell, P J J Herrod, B Doleman, et al.
Alimentary Pharmacology & Therapeutics|January 7, 2025
COLOFIT: Development and Internal-External Validation of Models Using Age, Sex, Faecal Immunochemical and Blood Tests to Optimise Diagnosis of Colorectal Cancer in Symptomatic PatientsC J Crooks, J West, J Jones, et al.
Pageof 2